期刊文献+

认识糖尿病视网膜病变临床研究热点难点,探索优化未来临床研究方向 被引量:12

Hot topics and unresolved issues in clinical researches of diabetic retinopathy
原文传递
导出
摘要 糖尿病视网膜病变(DR)临床研究涉及的领域庞大,选题方向广泛。DR与全身疾病的关系、发生发展的影响因素以及早期筛检发现手段、减少延缓DR发生发展的措施以及改进提高治疗效果的干预手段等一些围绕改善DR治疗效果的临床研究是目前DR临床研究的热点。但由于DR发病机制复杂,影响其发生发展的因素众多,导致DR防控周期长,涉及层面复杂以及DR临床研究中不易剔除的混杂因素较多均是DR临床研究的难点。从长远角度看,延缓DR发生和进展、建立高效实用的防控体系等方面的研究是未来应着重关注的研究方向。 There are many topics in clinical studies of diabetic retinopathy (DR). The current hot topics include the relationship between DR and systemic diseases, major factors for initiation and progression of DR, early DR screening strategies, DR prevention strategies and how to improve the therapeutic effects of DR. However, due to the complexity of DR pathogenesis, multiple risk factors, long cycle of DR prevention and control, it is difficult to exclude all the confounding factors in the DR clinical research. From the long-term perspective, delaying the occurrence and progression of DR and establishing an efficient and practical prevention and control system is the focus of the future DR research in China.
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2014年第2期121-123,共3页 Chinese Journal of Ocular Fundus Diseases
关键词 糖尿病视网膜病变 诊断 糖尿病视网膜病变 治疗 述评 Diabetic retinopathy/diagnosis Diabetic retinopathy/therapy Editorial
  • 相关文献

参考文献49

  • 1Xie XW, Xu L, Jonas jB, et al. Prevalence of diabetic retinopathy among subjects with known diabetes in China: the Beijing Eye Study [J]. Eur J Ophthalmol,2009, 19..91-99.
  • 2Wang FH, Liang YB, Zhang F, et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study [J]. Ophthalmology, 2009, 116 : 461-467.
  • 3Hamman RF, Mayer EJ, Moo-Young GA, et al. Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study [J]. Diabetes, 1989, 38 : 1231-1237.
  • 4Liew G, Mitchell P, Wong TY. Systemic management of diabetic retinopathy [J]. BMJ, 2009, 338 .. 441.
  • 5邹海东,张皙,朱剑锋,汪枫桦,许迅,王伟伟,吴美芳.上海市北新泾街道糖尿病患者视网膜病变的患病率调查[J].中华眼底病杂志,2006,22(1):31-34. 被引量:82
  • 6伍春荣,许樟荣,胡莲娜,王玉珍,敬华,罗灵.2型糖尿病发生增生性糖尿病视网膜病变的危险因素[J].中华眼底病杂志,2003,19(6):338-340. 被引量:42
  • 7Jones CD, Greenwood RH, Misra A, et al. Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England [J]. Diabetes Care,2012, 35:592-596.
  • 8Song H, Liu L, Sum R, et al. Incidence of diabetic retinopathy in a Hong Kong Chinese population [J]. Clin Exp Optom, 2011, 94:563-567.
  • 9Romero-Aroca P, Baget-Bernaldiz M, Fernandez-Ballart J, et al. Ten-year incidence of diabetic retinopathy and macular edema: risk factors in a sample of people with type 1 diabetes [J]. Diabetes Res Clin Pract,2011, 94:126-132.
  • 10Jimenez-Ramirez F, Perez R. Diabetic retinopathy education and screening at the community pharmacy in Puerto Rico [J]. P R Health Sci J,2011, 30:139-144.

二级参考文献84

  • 1曹景泰.生长因子与糖尿病性视网膜病变[J].国外医学(眼科学分册),1994,18(3):168-174. 被引量:15
  • 2金陈进,胡兆科,高汝龙.糖尿病性黄斑水肿及光凝治疗[J].中华眼底病杂志,1995,11(1):7-9. 被引量:12
  • 3李扬.糖尿病性黄斑水肿的激光治疗[J].国外医学(眼科学分册),1995,19(1):23-26. 被引量:11
  • 4全国糖尿病研究协作组调查研究组.全国14省市30万人口中糖尿病调查报告[J].中华内科杂志,1981,20(11):678-678.
  • 5黎晓新 姜燕荣 等.增殖性糖尿病视网膜病变玻璃体切割手术后视力及影响因素[J].中华眼底病杂志,1995,11:216-218.
  • 6中华医学会眼科学会眼底病学组.糖尿病视网膜病变分期标准[J].眼底病,1985,1:42-42.
  • 7杜治.糖尿病性黄斑水肿的治疗——氩激光和染料激光治疗的比较[J].国外医学:眼科学分册,1994,18:315-317.
  • 8陈国辉 沈雅舟 陈国辉 主编.糖尿病的眼部并发症[A].沈雅舟,陈国辉,主编.糖尿病慢性并发症[C].上海:上海医科大学出版社,1998.55-65.
  • 9Kocur I,Resnikoff S.Visual impairment and blindness in Europe and their prevention.Br J Ophthalmol,2002,86:716-722.
  • 10Rodriguez J,Sanchez R,Munoz B,et al.Causes of blindness and visual impairment in a population-based sample of U.S.Hispanics.Ophthalmology,2002,109:737-743.

共引文献248

同被引文献87

  • 1罗丽勇,柯东荣.糖尿病性视网膜病变5年治疗随访观察与防治措施[J].广东医学,2005,26(8):1119-1120. 被引量:3
  • 2李蕾,薛元明,康亚萍,施珏,张云,马杉.2型糖尿病患者糖尿病视网膜病变患病率及其相关危险因素[J].中华糖尿病杂志(1006-6187),2005,13(5):338-339. 被引量:42
  • 3张红霞,贾伟平,包玉倩,贾丽丽,左玉华,项坤三.免散瞳眼底拍照对糖尿病视网膜病变筛查效果的评价[J].中国糖尿病杂志,2007,15(7):395-396. 被引量:23
  • 4伍春荣,马志中,胡莲娜,许樟荣,任正洪.糖尿病视网膜病变相关因素的因子分析[J].国际眼科杂志,2007,7(4):1056-1059. 被引量:28
  • 5Zheng Z, Chen H, Wang H, et al. Improvement of retinal vascular injury in diabetic rats by statins is associated with the inhibition of mitochondrial reactive oxygen species pathway mediated by peroxisome proliferator-activated receptor gamma coactivatorl alpha [ J]. Diabetes,2010,59:2315-2325.
  • 6Wei WB, Xu L, Jonas JB,et al. Subfovealchoroidal thickness : the Beijing Eye Study [J]. Ophthalmology,2013,120 : 175-180.
  • 7Wu L,Tao Q, Chen W, et al. Association between polymorphisms of complement pathway genes and age-related macular degeneration in a Chinese population [ J]. Invest Ophthalmol Vis Sci ,2013,54 : 170-174.
  • 8Tian J,Yu W,Qin X,et al. Association of genetic polymorphisms and age-related macular degeneration in Chinese population [ J ]. Invest Ophthalmol Vis Sci, 2012,53:4262-4269.
  • 9Xu Y, Zhang Q, Kang X, et al. Early vitreoretinal surgery on vascularly active stage 4 retinopathy of prematurity through the preoperative intravitrealbevacizumabinjection [ J ]. Acta Ophthalmol, 2013,91 : e304-310.
  • 10Zhao H, Jin H, Li Q, et al. Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a) [ J]. Invest Ophthalmol Vis Sci, 2009,50: 5384-5395.

引证文献12

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部